All Type of News
United Pharm to export anti-inflammatory drug to Europe
Korea United Pharm Inc. said on Feb. 6 that it will export its anti-inflammatory drug Clanza CR tablets (aceclofenac 200 mg) to Russia and four Eastern European countries under a distribution agreement with the world’...
Dong-A seeks overseas expansion
Top local drug maker Dong-A Pharmaceutical is ramping up its overseas expansion drive this year, with the aim to boost overseas growth.
The Seoul-based company, which already established subsidiaries, in the U.S. a...
Pfizer Korea, top sponsor of clinical trials in 2012
Pfizer Korea led any other companies in the number of clinical trials approved last year, according to the Korea Food and Drug Administration (KFDA).
The KFDA approved 46 clinical trials requested by Pfizer Korea. ...
Multinational clinical studies are increasing, KFDA says
The number of multinational clinical trials conducted by multinational pharmaceutical companies in Korea reached 303 last year, showing a 56-percent increase from a year earlier, according to the Korea Food and Drug A...
SK Chemicals seeks bigger market share in Europe
SK Chemicals, Korea’s leading pharmaceutical and chemical products manufacturer, is gearing up to boost its marketing activities in Europe with its dementia patch treatment, named SID710 (rivastigmine), was approved b...
US FDA approval for Kynamro supported by Korean toxicology center
The U.S. Food and Drug Administration on Jan. 29 approved Kynamro (mipomersen sodium) injection as an addition to lipid-lowering medications and diet to treat patients with a rare type of high cholesterol called homoz...
Medical industry promises to clean house
The Korean Medical Association renewed its efforts yesterday to eradicate drug company rebates but still blamed the government’s dual punishment system adopted in November 2011.
The dual punishment system penalizes...
Medical sector vows to stem rebates
Korea’s two umbrella organizations for medical doctors vowed efforts yesterday to eradicate drug company rebates.
The Korea Medical Clinic Association (KMCA) and the National Union of Korean Medical Doctors (NUKMD)...
Concerns mounting over doctors’ pledge to eradicate drug rebates
The Korean Medical Association and the Korean Academy of Medical Sciences said on Monday that they will come up with their own disciplinary measures to discourage their members from taking rebates from pharmaceutical ...
Jakavi approved in Korea
Novartis Korea has recently received approval from the Korea Food and Drug Administration for Jakavi (INC424, ruxolitinib tablets), a drug for the treatment of disease-related splenomegaly and/or its associated sympto...
